T1	Participants 213 260	patients with bone marrow transplantation (BMT)
T2	Participants 322 345	patients undergoing BMT
T3	Participants 385 465	66 patients with 43 hematologic and 23 solid malignancies (21 breast carcinomas)
T4	Participants 761 799	Patients with hematologic malignancies
T5	Participants 956 997	Patients with solid malignancies (n = 23)
